Let’s talk about gene therapy
To help us have a conversation about how gene therapy could impact those who live with, treat or care for someone with haemophilia, BioMarin conducted the world’s first piece of research specifically aimed at the language used in discussing this new approach.
A ground breaking study
Through our pioneering research, we’ve developed a recommended language that can effectively communicate information about gene therapy for haemophilia.
To find out more, watch the video below.
Want to know more?
For more information, download the FREE lexicon on gene therapy offered by BioMarin and the original qualitative study.
Download Brochure
If you would like to understand more about the topic of gene therapy by having accurate and straightforward information please visit https://www.haemdifferently.eu/
Disclaimer: BioMarin maintains this website to enhance public access to information about communicating with patients about gene therapy. Our goal is to keep this information timely and accurate. If errors are brought to our attention, we will try to correct them. However, BioMarin accepts no responsibility or liability whatsoever with regard to the information on this site. All information is provided “as is”. BioMarin accepts no responsibility with regard to website errors, interrupted service or other problems incurred as a result of using this site.
Copyright notice: © 2022 BioMarin International Ltd. Reproduction of content owned by BioMarin on this website is authorised, provided the source is acknowledged. Any software or documents covered by industrial property rights, such as patents, trademarks, registered designs, logos and names, are excluded from BioMarin’s reuse policy and are not licensed to you.
EU/GTH/0015 January 2022